selected publications
- Targeting cancer's sweet spot: UGP2 as a therapeutic vulnerability. Molecular & cellular oncology. 2021 Academic Article GET IT
-
UDP-glucose pyrophosphorylase 2, a regulator of glycogen synthesis and glycosylation, is critical for pancreatic cancer growth.
Proceedings of the National Academy of Sciences of the United States of America.
2021
Academic Article
GET IT
Times cited: 22 -
NOTCH and EZH2 collaborate to repress PTEN expression in breast cancer.
Communications biology.
2021
Academic Article
GET IT
Times cited: 21 -
NRF2 Activation Confers Resistance to eIF4A Inhibitors in Cancer Therapy.
Cancers.
2021
Academic Article
GET IT
Times cited: 13 -
Cystic Fibrosis Transmembrane Conductance Regulator Attaches Tumor Suppressor PTEN to the Membrane and Promotes Anti Pseudomonas aeruginosa Immunity.
Immunity.
2017
Academic Article
GET IT
Times cited: 47 -
Characterization of a set of tumor suppressor microRNAs in T cell acute lymphoblastic leukemia.
Science signaling.
2014
Academic Article
GET IT
Times cited: 39 -
RNA G-quadruplexes cause eIF4A-dependent oncogene translation in cancer.
Nature.
2014
Academic Article
GET IT
Times cited: 472 -
The Eph-receptor A7 is a soluble tumor suppressor for follicular lymphoma.
Cell.
2011
Academic Article
GET IT
Times cited: 147 -
Targeting cap-dependent translation blocks converging survival signals by AKT and PIM kinases in lymphoma.
The Journal of experimental medicine.
2011
Academic Article
GET IT
Times cited: 100 -
Genome-wide RNA-mediated interference screen identifies miR-19 targets in Notch-induced T-cell acute lymphoblastic leukaemia.
Nature cell biology.
2010
Academic Article
GET IT
Times cited: 305